Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-091961
Filing Date
2024-10-30
Accepted
2024-10-30 08:20:35
Documents
54
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0218371-10q_cormedix.htm   iXBRL 10-Q 790228
2 CERTIFICATION ea021837101ex31-1_cormedix.htm EX-31.1 10387
3 CERTIFICATION ea021837101ex31-2_cormedix.htm EX-31.2 10680
4 CERTIFICATION ea021837101ex32-1_cormedix.htm EX-32.1 3785
5 CERTIFICATION ea021837101ex32-2_cormedix.htm EX-32.2 3931
  Complete submission text file 0001213900-24-091961.txt   4630637

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20240930.xsd EX-101.SCH 33170
7 XBRL CALCULATION FILE crmd-20240930_cal.xml EX-101.CAL 41969
8 XBRL DEFINITION FILE crmd-20240930_def.xml EX-101.DEF 198467
9 XBRL LABEL FILE crmd-20240930_lab.xml EX-101.LAB 370163
10 XBRL PRESENTATION FILE crmd-20240930_pre.xml EX-101.PRE 205366
56 EXTRACTED XBRL INSTANCE DOCUMENT ea0218371-10q_cormedix_htm.xml XML 540063
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 241407530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)